Product Information
INDAPAMIDE 2.5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1113 per EA under NDC 16571087601. Its NADAC has been published 147 times since Sep 6, 2023.
Strength
2.5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571087601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
INDAPAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074461On Market Since
6/22/2023
Pharmacological Classes
Price Statistics
The NADAC for INDAPAMIDE 2.5 MG TABLET has been published 147 times since Sep 6, 2023, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1113 per EA |
|---|---|
| All-time high | $0.1414 (Feb 14, 2024) |
| All-time low | $0.0899 (Nov 20, 2024) |
| 52-week high | $0.1202 |
| 52-week low | $0.1030 |
| Median price | $0.1177 |
| Average price | $0.1176 |
| Largest weekly change | +38.8% (Jun 19, 2024) |
| Weeks tracked | 147 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INDAPAMIDE 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 2.5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1113 per EA (NDC 16571087601), effective Jun 24, 2026.
How has the price of INDAPAMIDE 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for INDAPAMIDE 2.5 MG TABLET has declined 7.5%. It has been tracked across 147 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for INDAPAMIDE 2.5 MG TABLET?
Since Sep 6, 2023, the NADAC for INDAPAMIDE 2.5 MG TABLET has ranged from a low of $0.0899 (Nov 20, 2024) to a high of $0.1414 (Feb 14, 2024), with a median of $0.1177 per EA.
Are there cheaper alternatives to INDAPAMIDE 2.5 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as INDAPAMIDE 2.5 MG TABLET, but none are currently priced below it.
Who manufactures INDAPAMIDE 2.5 MG TABLET?
INDAPAMIDE 2.5 MG TABLET (NDC 16571087601) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification